Sign up
LIPO

Lipella Pharmaceuticals Inc. Common Stock (NASDAQ: LIPO)

Healthcare · Biotechnology

$0.00

Last close · Nov 17, 2026 · NASDAQ USD

Set alert

The Quantellect read. Short interest is 0.03% of float with a 43.36% borrow fee. Zero active firms cover the stock as of Nov 19, 2026; zero active firms with targets average $10.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuationLower multiples than peers

P/S 0.0× vs peer median 13.9×

Momentum—

—

TrendBelow both averages

$0.00 vs $0.03 and $0.21 · as of Nov 17, 2026

Short interest0.0% of float

FINRA settlement Oct 30, 2026

LIPO price chart

Price $0.00 · As of Nov 18, 2026, 8:39 PM ET

Open full chart →
Nov 17, 2026O $0.00H $0.00L $0.00C $0.00Vol 1K

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First dateMay 18, 2026 ET
Last dateNov 17, 2026 ET
Open$0.03
High$0.17
Low$0.00
Close$0.00
Volume1,878,881
Plotted bars58

Plotted OHLCV bars

  1. May 18, 2026 ET · Open $0.03 · High $0.11 · Low $0.03 · Close $0.09 · Volume 171,041
  2. May 19, 2026 ET · Open $0.09 · High $0.17 · Low $0.09 · Close $0.17 · Volume 102,123
  3. May 20, 2026 ET · Open $0.17 · High $0.17 · Low $0.10 · Close $0.14 · Volume 94,055
  4. May 21, 2026 ET · Open $0.14 · High $0.14 · Low $0.14 · Close $0.14 · Volume 17,988
  5. May 22, 2026 ET · Open $0.13 · High $0.13 · Low $0.10 · Close $0.10 · Volume 25,953
  6. Jun 1, 2026 ET · Open $0.10 · High $0.15 · Low $0.10 · Close $0.11 · Volume 59,176
  7. Jun 2, 2026 ET · Open $0.10 · High $0.11 · Low $0.10 · Close $0.10 · Volume 18,897
  8. Jun 3, 2026 ET · Open $0.09 · High $0.10 · Low $0.08 · Close $0.08 · Volume 121,154
  9. Jun 5, 2026 ET · Open $0.08 · High $0.12 · Low $0.08 · Close $0.11 · Volume 128,261
  10. Jun 8, 2026 ET · Open $0.10 · High $0.10 · Low $0.09 · Close $0.10 · Volume 100,095
  11. Jun 9, 2026 ET · Open $0.09 · High $0.09 · Low $0.08 · Close $0.08 · Volume 19,651
  12. Jun 10, 2026 ET · Open $0.08 · High $0.08 · Low $0.07 · Close $0.08 · Volume 67,870
  13. Jun 15, 2026 ET · Open $0.08 · High $0.15 · Low $0.08 · Close $0.10 · Volume 180,286
  14. Jun 16, 2026 ET · Open $0.10 · High $0.10 · Low $0.10 · Close $0.10 · Volume 18,881
  15. Jun 17, 2026 ET · Open $0.07 · High $0.07 · Low $0.06 · Close $0.06 · Volume 119,519
  16. Jun 18, 2026 ET · Open $0.08 · High $0.09 · Low $0.08 · Close $0.08 · Volume 64,867
  17. Jun 23, 2026 ET · Open $0.08 · High $0.08 · Low $0.08 · Close $0.08 · Volume 2,581
  18. Jun 25, 2026 ET · Open $0.09 · High $0.09 · Low $0.09 · Close $0.09 · Volume 23,494
  19. Jun 29, 2026 ET · Open $0.08 · High $0.09 · Low $0.06 · Close $0.06 · Volume 161,130
  20. Jun 30, 2026 ET · Open $0.11 · High $0.12 · Low $0.11 · Close $0.11 · Volume 75,172
  21. Jul 1, 2026 ET · Open $0.13 · High $0.13 · Low $0.13 · Close $0.13 · Volume 162
  22. Jul 6, 2026 ET · Open $0.12 · High $0.12 · Low $0.05 · Close $0.08 · Volume 104,203
  23. Jul 7, 2026 ET · Open $0.08 · High $0.09 · Low $0.07 · Close $0.07 · Volume 23,156
  24. Jul 8, 2026 ET · Open $0.07 · High $0.07 · Low $0.07 · Close $0.07 · Volume 28,998
  25. Jul 13, 2026 ET · Open $0.07 · High $0.07 · Low $0.07 · Close $0.07 · Volume 10,061
  26. Jul 14, 2026 ET · Open $0.07 · High $0.07 · Low $0.07 · Close $0.07 · Volume 25,405
  27. Jul 15, 2026 ET · Open $0.07 · High $0.07 · Low $0.06 · Close $0.06 · Volume 11,205
  28. Jul 17, 2026 ET · Open $0.06 · High $0.06 · Low $0.03 · Close $0.03 · Volume 3
  29. Aug 4, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 592
  30. Aug 5, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 320
  31. Aug 6, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 202
  32. Aug 11, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 1,244
  33. Aug 17, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 7,010
  34. Aug 18, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 3,800
  35. Aug 19, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 1,512
  36. Aug 24, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 500
  37. Aug 25, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 22,509
  38. Sep 1, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 632
  39. Sep 2, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 1,061
  40. Sep 11, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 1,487
  41. Sep 14, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 400
  42. Sep 18, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 217
  43. Sep 24, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 1,001
  44. Sep 29, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 5,993
  45. Sep 30, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 2,037
  46. Oct 1, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 100
  47. Oct 2, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 594
  48. Oct 7, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 2,894
  49. Oct 9, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 300
  50. Oct 12, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 236
  51. Oct 16, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 400
  52. Oct 20, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 310
  53. Oct 23, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 915
  54. Oct 26, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 1,682
  55. Oct 28, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 353
  56. Nov 4, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 645
  57. Nov 11, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 43,343
  58. Nov 17, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 1,205

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of Nov 18, 2026, 8:39 PM ET

Initial 6M price range summary
Range6M
First close$0.09
Last close$0.00
High$0.17
Low$0.00
Volume1,878,881
Open
—Historical · Nov 17, 2026
Previous close
—Historical · Nov 17, 2026
Day range
—Historical · Nov 17, 2026
52-week range—
Volume
—Historical · Nov 17, 2026
Average volume (30 calendar days)—
Market cap—
P/E (TTM)—
Forward P/E—
EPS (TTM)—
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)—

Price history

LIPO · nasdaq · USD

Last completed session: Nov 17, 2026

Split-adjusted · volume in shares

Missing sessions: Nov 2, 2026, Nov 3, 2026, Nov 5, 2026, Nov 6, 2026, Nov 9, 2026, Nov 10, 2026, Nov 12, 2026, Nov 13, 2026, Nov 16, 2026, Nov 18, 2026

November 2026 · 3 completed sessions
DateOpenHighLowCloseChangeVolume
0.00040.00040.00040.0004—1,205
Open 0.0004High 0.0004Low 0.0004
0.00060.00060.00060.0006—43,343
Open 0.0006High 0.0006Low 0.0006
0.00050.00050.00050.0005—645
Open 0.0005High 0.0005Low 0.0005

Notable price movement

Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.

  1. $0.00−33.33%

    Trading volume was 0.2 times the 30-day average, with 1.21K shares traded.

  2. $0.00+20.00%

    Trading volume was 66.8 times the 30-day average, with 43.34K shares traded.

  3. $0.00−16.67%

    Trading volume was 0.7 times the 30-day average, with 645 shares traded.

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide76High Tide—
Squeeze18Idle—
How the scores work →

How LIPO compares with its industry

Against 592 other US-listed Biotechnology stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Strongest points

  1. One-month return was 0%, higher than 76% of 567 peers.Peer median −13.9% · As of Nov 16, 2026

Points of caution

  1. Trailing-year return on equity was -361.8%, with only 11% of 554 peers reporting a lower value.Peer median −67.8% · As of Nov 17, 2026
  2. Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026
  3. Latest-quarter year-over-year sales growth was -36.4%, with only 24% of 592 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026

Valuation

Lower multiples than peers

  • Price/sales0.01×13.90×
    Lowest 10%

    Higher than 1% of 407 peers

  • Forward P/E—14.90×

    Not ranked: only 194 of 592 peers report it

  • Price/book0.00×2.58×
    Lowest 10%

    Higher than 1% of 551 peers

Profitability

Profitability metrics are lower than most peers.

  • Gross margin—78.4%

    Not ranked: only 247 of 592 peers report it

  • Operating margin—0.0%

    Not ranked: only 443 of 592 peers report it

  • Net margin0.0%0.0%

    Higher than 19% of 583 peers

  • Return on equity−361.8%−67.8%

    Higher than 11% of 554 peers

Growth

Growth metrics are lower than most peers.

  • Quarterly sales growth, year over year−36.4%0.0%

    Higher than 24% of 592 peers

  • 5-year sales growth rate—11.3%

    Not ranked: only 140 of 592 peers report it

Balance sheet

Balance sheet metrics are lower than most peers.

  • Current ratio3.245.03

    Higher than 34% of 498 peers

  • Debt/equity (total borrowings)—0.23

    Not ranked: only 117 of 592 peers report it

Momentum

Not enough peers report returns for a group comparison.

  • 1-year return—−28.4%

    Not ranked: only 523 of 592 peers report it

  • 6-month return—−26.6%

    Not ranked: only 546 of 592 peers report it

  • 3-month return—−29.8%

    Not ranked: only 559 of 592 peers report it

Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 13, 2026

Upcoming events

— · Upcoming events not available

Analyst consensus

No Coverage

0Strong Buy
0Buy
0Neutral
0Sell
0Strong Sell

Based on 0 active firms as of Nov 19, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$10.00
Average$10.00
High$10.00

As of Nov 19, 2026 across 0 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

EPS, last 8 quarters
EstimateBeatMissMatch
Fiscal periodEst.ActualResult
Q3 2025$0.00−$0.28—
Q2 2025$0.00−$0.31—
Q1 2025—−$0.64—
Annual 2024−$2.43−$4.79—
Q3 2024−$0.96−$1.29—
Q2 2024−$1.04−$0.12—
Q1 2024—−$0.16—
Annual 2023—−$0.77—

Smart-money activity

In the last 60 days: 0 insider sales and 0 purchases. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
Insider buyKaufman Jonathan HBuy$7.6KForm 4
Insider buyKaufman Jonathan HBuy$21.8KForm 4
Insider buyKaufman Jonathan HBuy$23.6KForm 4
All smart-money activity →

News and press releases

News and press releases are not available.

All LIPO news →

Company profile

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and

CEO
Dr. Jonathan Kaufman M.B.A., Ph.D.
Headquarters
Pittsburgh, PA, United States
Employees
5
IPO date
Dec 19, 2022
Sector
Healthcare
Industry
Biotechnology

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.